Remodeling Failing Human Myocardium With Hybrid Cell/Matrix and Transmyocardial Revascularization
暂无分享,去创建一个
[1] Raymond B. Runyan,et al. Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging , 2017, Journal of Cardiothoracic Surgery.
[2] Raymond B. Runyan,et al. Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapy , 2016, SpringerPlus.
[3] J. Moraleda,et al. Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application , 2014, Stem cells and cloning : advances and applications.
[4] G. Scheiner-Bobis,et al. Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. , 2013, American journal of stem cells.
[5] Daniel Berman,et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.
[6] R. Shemin,et al. The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization. , 2004, The Annals of thoracic surgery.
[7] M. Coughlin. Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory Angina , 2001 .
[8] M. Matsuzaki,et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. , 2000, The Journal of surgical research.
[9] Robert D. Dowling,et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. , 1999, The New England journal of medicine.
[10] K. Horvath. Transmyocardial Laser Revascularization , 1995, Journal of cardiac surgery.